Finapark is a monoamine oxidase type B (MAO-B) inhibitor indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing "off" episodes. It is not effective as a monotherapy for Parkinson’s disease
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
The exact mechanism of action of Safinamide Mesylate in Parkinson’s disease is not fully understood. Safinamide Mesylate inhibits monoamine oxidase B (MAO-B), which prevents the breakdown of dopamine, resulting in increased dopamine levels and enhanced dopaminergic activity in the brain.
There is limited experience with Safinamide overdose. If an overdose occurs, discontinue treatment and provide supportive care, including dietary restriction of tyramine for several weeks.
Common side effects include dyskinesia, falls, nausea, and insomnia.
Store below 30°C, away from light, and out of the reach of children.lofenac Potassium 50 mg Tablet, Acme Laboratories Ltd.